Statins could boost male resistance to respiratory infection

Drugs that mimic part of the role of oestrogen - including statins - could increase resistance to respiratory infection in men at high risk, research suggests.

Sneeze: statins could boost resistance to respiratory infection (Photo: iStock)
Sneeze: statins could boost resistance to respiratory infection (Photo: iStock)

An international study, headed by researchers at Harvard University, found that the nitric oxide synthase-3 (NOS3) enzyme improved bacterial clearance in the lungs and played a crucial role in preventing associated respiratory diseases such as pneumonia.

Activation of the NOS3 enzyme is dependent on the female sex hormone oestrogen, which may help explain why women tend to be naturally more resistant to respiratory infections than men.

Drugs that mimic oestrogen’s role in targeting NOS3 activation – such as statins – could be used as a preventative measure to help raise resistance in men at high risk of respiratory infection, the findings suggest.

In a series of experiments, published in the eLife journal, the researchers introduced Streptococcus pneumoniae into the lungs of mice.

To observe the effects of NOS3 on the bacteria, they treated some of the male mice with oestrogen. They found that female mice and these treated male mice were better at clearing out bacteria responsible for pneumonia and other infections than the ordinary males. They also had less acute inflammation after 24 hours.

Drugs that target NOS3 activation

In mice with the gene responsible for producing NOS3 removed, female bacterial resistance fell to be more in line with their male counterparts, further suggesting activation of this enzyme was driving the heightened resistance normally observed in females.

‘Ultimately, this work could be especially useful in reducing risk of secondary bacterial pneumonias during seasonal or pandemic influenza,’ said Professor Lester Kobzik, the senior author.

‘We were quite pleased that the work led us to NOS3-targeting drugs that are already available and that can indeed improve resistance to pneumonia in our mouse model.’

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

First-dose COVID-19 vaccine supply for GP sites to stop completely for a fortnight

First-dose COVID-19 vaccine supply for GP sites to stop completely for a fortnight

Supplies of COVID-19 vaccine for first-dose vaccinations at GP-led vaccination sites...

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...

More than 70% of COVID-19 jabs this month have been second doses

More than 70% of COVID-19 jabs this month have been second doses

More than seven in 10 COVID-19 jabs administered UK-wide since the start of April...

Accountant's theft of more than £60,000 from GP practices uncovered in pandemic

Accountant's theft of more than £60,000 from GP practices uncovered in pandemic

An accountant has been handed a suspended jail term after stealing more than £60,000...

GMC to contact thousands of GPs due to revalidate from August

GMC to contact thousands of GPs due to revalidate from August

The GMC is writing to thousands of doctors due to revalidate from August to set out...

NHS England spells out next steps as GPs told to cancel AZ jabs booked for under-30s

NHS England spells out next steps as GPs told to cancel AZ jabs booked for under-30s

GP-led vaccination sites should offer under-30s due to receive a first dose of AstraZeneca...